pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
the cabinet
Drugs
8,127
products tracked ·
1,831
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
melphalan hydrochloride
Melblez (melphalan hydrochloride)
Bile Duct Cancer (Cholangiocarcinoma)
$DCTH
DELCATH SYSTEMS, INC.
Marketed
mercaptopurine
Purixan (mercaptopurine)
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…
Rare Disease Therapeutics Inc
Phase 1
metarrestin
Breast Cancer
U.S. National Institutes of Health
← prev
page 51 of 62
next →
Pain
89
Neurology
1
Marketed
methoxsalen
Methoxsalen
Vitiligo
Allergan Finance LLC
Marketed
methyltestosterone
Methyltestosterone
Hormone Sensitive Breast Cancer
Novitium Pharma LLC
Phase 2
metyrosine
Metyrosine
Autism Spectrum Disorder (ASD)
Yamo Pharmaceuticals LLC
Phase 3
mezigdomide
mezigdomide
Refractory Multiple Myeloma
Bristol-Myers Squibb Co
Phase 2
micvotabart pelidotin
micvotabart pelidotin [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast…
$PYXS
Pyxis Oncology, Inc.
Marketed
midostaurin
Midostaurin
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Lupin Ltd
Phase 2
mifomelatide
mifomelatide [INN]
Cancer Anorexia-Cachexia Syndrome
Kalohexis LLC
Phase 2
mipletamig
mipletamig [INN]
Refractory Acute Myeloid Leukemia
$APVO
Aptevo Therapeutics Inc.
Marketed
mirdametinib ODT
Gomekli (mirdametinib)
Neurofibromatoses Type I (Von Recklinghausen's Disease)
SpringWorks Therapeutics Inc
Marketed
mirvetuximab soravtansine
Elahere (mirvetuximab soravtansine-gynx)
Epithelial Ovarian Cancer
ImmunoGen Inc
Phase 2
mitazalimab
mitazalimab [INN]
Pancreatic Ductal Adenocarcinoma
Alligator Bioscience AB
Phase 2
mitolactol
mitolactol [INN]
Glioblastoma Multiforme (GBM)
Eleison Pharmaceuticals Inc
Marketed
mitotane
Lysodren (mitotane)
Adrenocortical Carcinoma (Adrenal Cortex Cancer)
Esteve Pharmaceuticals SA
Marketed
mitoxantrone hydrochloride
Mitoxantrone Hydrochloride
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Nanjing King-friend Biochemical Pharmaceutical Co Ltd
Phase 2
mocaciclib
mocaciclib [INN]
Endometrial Cancer
Qurient Co Ltd
Phase 3
mocravimod hydrochloride
mocravimod hydrochloride
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
Priothera Ltd
Marketed
motixafortide acetate
motixafortide acetate
Metastatic Adenocarcinoma of The Pancreas
$BLRX
BioLineRx Ltd.
Phase 2
mozistobart zoratolimod
mozistobart zoratolimod [INN]
Bile Duct Cancer (Cholangiocarcinoma)
Tallac Therapeutics Inc
Phase 2
mupadolimab
mupadolimab
Non-Small Cell Lung Cancer
$CRVS
Corvus Pharmaceuticals, Inc.
Phase 2
muzastotug
muzastotug [INN]
Solid Tumor
$ADAG
Adagene Inc.
Marketed
nadofaragene firadenovec
Adstiladrin (nadofaragene firadenovec)
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial B…
Ferring Pharmaceuticals Inc
Phase 3
nadunolimab
nadunolimab [INN]
Pancreatic Ductal Adenocarcinoma
Cantargia AB
Phase 3
namodenoson
namodenoson
Hepatocellular Carcinoma
$CANF
Can-Fite BioPharma Ltd.
Preclinical
nanoencorafenib
Colorectal Cancer
Nanoform Finland Plc
Phase 3
nanvuranlat
nanvuranlat [INN]
Metastatic Biliary Tract Cancer
J-Pharma Co Ltd
Phase 2
narmafotinib tartrate
narmafotinib tartrate
Metastatic Adenocarcinoma of The Pancreas
Amplia Therapeutics Ltd
Phase 2
navicixizumab
navicixizumab
Fallopian Tube Cancer
Feng Biosciences Inc
